
Jack L. Johnson, President, IHMA, Inc.
Jack founded IHMA in 1992 after spending approximately 18 years in the pharmaceutical industry with Pfizer, Beecham Laboratories and G.D. Searle in various roles including, sales and management. During those years he was responsible for the launch of cefoperazone, amoxicillin/clavulanic acid, ticarcillin/clavulanic acid, mupirocin and lomefloxacin. His responsibilities included both domestic and international assignments. Prior to joining the pharmaceutical industry, he spent a number of years in both hospital and private microbiology laboratories assuming various bench and management roles.